AzTrials
AzTrials

Physical MedicineNCT03595605

Association Between Inpatient Steps Per Day and Patient Functional Status/Disposition

A study testing Ambulation in people with Physical Medicine, run by NYU Langone Health at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study will incorporate the use of wearable actigraphy devices (Fitbit) on research participants admitted to medicine inpatient units at Tisch Hospital and/or NYU Brooklyn. The investigator's sample size will be 600 randomized into two groups, with basic inclusion criteria including age greater than 65 years and… Read more about this study

Who is it for?
Ages 66 to 100 years
Conditions the study is for
Physical Medicine
What is being tested?
Ambulation
Could I receive a placebo?
No, everyone receives an active treatment
How many people
51 participants
Where
1 siteUnited States
Study dates
16 May 2018to 30 Mar 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 66 to 100 years
  • All sexes
  • No healthy volunteers
  • Older adult

Who may be able to join

  • Admitted to acute inpatient medicine unit
  • Ambulatory without assistive device prior to hospitalization
  • Medical clearance to ambulate on the unit
  • Active MyChart account or willing to activate MyChart account
  • iOS or Android device

Who cannot join

  • Patients less than or equal to 65 years old
  • Not Admitted to acute inpatient medicine unit
  • Ambulatory with assistive device prior to hospitalization
  • No Medical clearance to ambulate on the unit
  • Inactive MyChart account and not willing to activate MyChart account
  • No iOS or Android device
Show all 14Show fewer
  • In addition, an individual who meets any of the following criteria will be excluded from participation in this study:
  • Oxygen requirement at rest
  • Lower extremity prosthesis
  • Admitted for joint replacement surgery
  • History of frequent falls
  • Admitted for syncope.
  • If patients have specifically opted out of being contacted about research (visible in the Epic header while in their chart)
  • Admitted from nursing home

Trial locations and contacts

1 site in 1 country.

United States1 site
  • New York University School of Medicine

    New York, New York, 10016

Other trials in United States

About this study

This study will incorporate the use of wearable actigraphy devices (Fitbit) on research participants admitted to medicine inpatient units at Tisch Hospital and/or NYU Brooklyn. The investigator's sample size will be 600 randomized into two groups, with basic inclusion criteria including age greater than 65 years and pre-hospital ambulatory status. While both groups will be monitored in terms of their activity (specifically pedometer data), the intervention group will have twice daily encouragement of ambulation. Once a subject is enrolled, data will be collected daily and at time of discharge.

Being tested
Ambulation, Standard of Care

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • AmbulationBehavioural

    This group will be encouraged twice daily to ambulate

  • Standard of CareOther

    Care as usual at inpatient NYU Langone

Study groups in NCT03595605
Study groupRoleWhat they receive
FitBit GroupExperimentalWill receive a wearable device (FitBit) designed to track number of steps for the duration of their hospital stay. They will receive nudges twice/day to ambulate
Receives: Behavioral: Ambulation
Control Group-Standard of CareActive comparator300 subjects who will receive usual standard of care on a general inpatient medicine unit with the addition of a wearable device (FitBit) to track usual mobility in this setting. will complete their admission without push for increased activity (although having the device may influence their steps taken).
Receives: Other: Standard of Care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Determine how many steps patients admitted to the medicine units are taking at baseline

    Steps will be measured using a wearable device (FitBit) designed to track number of steps for the duration of their hospital stay

    Measured: 1 Day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Jul 2018
  2. Study start16 May 2018
  3. Primary completion30 Mar 2019
  4. Study completion30 Mar 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
51 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03595605
Sponsor's protocol ID
17-01792
Status last verified
May 2020
First submitted
22 May 2018
Last updated
29 May 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Ambulation in people with Physical Medicine, run by NYU Langone Health at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 14 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 29 May 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Determine how many steps patients admitted to the medicine units are taking at baseline (time frame: 1 Day). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 May 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in